(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 23.75% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Electrocore's revenue in 2026 is $36,966,000.On average, 7 Wall Street analysts forecast ECOR's revenue for 2026 to be $385,465,147, with the lowest ECOR revenue forecast at $365,558,073, and the highest ECOR revenue forecast at $405,994,317. On average, 7 Wall Street analysts forecast ECOR's revenue for 2027 to be $499,966,887, with the lowest ECOR revenue forecast at $455,798,066, and the highest ECOR revenue forecast at $549,887,842.
In 2028, ECOR is forecast to generate $635,511,702 in revenue, with the lowest revenue forecast at $574,131,557 and the highest revenue forecast at $710,442,722.